Rhumbline Advisers Has $13.57 Million Stake in Maximus, Inc. (NYSE:MMS)

Rhumbline Advisers cut its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 3.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 199,018 shares of the health services provider's stock after selling 6,241 shares during the period. Rhumbline Advisers owned approximately 0.35% of Maximus worth $13,571,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in MMS. Vanguard Group Inc. lifted its holdings in shares of Maximus by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock valued at $488,829,000 after purchasing an additional 205,564 shares in the last quarter. Mackenzie Financial Corp lifted its holdings in shares of Maximus by 2.0% in the fourth quarter. Mackenzie Financial Corp now owns 2,782,150 shares of the health services provider's stock valued at $207,687,000 after purchasing an additional 55,583 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Maximus by 14.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider's stock valued at $105,001,000 after purchasing an additional 177,075 shares in the last quarter. Van Berkom & Associates Inc. lifted its holdings in shares of Maximus by 8.5% in the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock valued at $93,792,000 after purchasing an additional 98,264 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Maximus by 7.4% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 1,234,933 shares of the health services provider's stock valued at $92,188,000 after purchasing an additional 84,835 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Maximus Stock Down 1.3%

MMS traded down $0.95 on Wednesday, hitting $70.45. 426,899 shares of the company were exchanged, compared to its average volume of 567,056. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97. The company has a market cap of $3.97 billion, a PE ratio of 15.15 and a beta of 0.62. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The stock's fifty day moving average is $70.30 and its 200-day moving average is $71.21.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.64. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same quarter in the prior year, the company posted $1.57 earnings per share. Maximus's revenue was up 1.0% on a year-over-year basis. Equities research analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Saturday, May 31st. Investors of record on Thursday, May 15th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Thursday, May 15th. This represents a $1.20 annualized dividend and a yield of 1.70%. Maximus's payout ratio is presently 23.86%.

Insider Buying and Selling

In other Maximus news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Gayathri Rajan sold 7,913 shares of the business's stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $72.38, for a total value of $572,742.94. Following the transaction, the director now directly owns 14,205 shares in the company, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.